This project involved direction of an intense focused ultrasound beam at the region of the ciliary body to cause cyclodestruction. This project eventually led to a commercial device (Sonocare, Inc.) manufactured under license by Cornell, and a multicenter clinical trial.
This undertaking entailed steering a concentrated ultrasound beam at the ciliary body area to induce cyclodestruction. This project ultimately led to a commercial device (Sonocare, Inc.) manufactured under license by Cornell, and a multicenter clinical trial.